Vanessa Raabe

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · New England Journal of Medicine · 2020 · 2.7K citations · Full text

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text

Tuberculosis following PD-1 blockade for cancer immunotherapy

Daniel L. Barber, Shunsuke Sakai, Ragini R. Kudchadkar et al. · Science Translational Medicine · 2019 · 193 citations · Full text

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · 2020 · 155 citations · Full text

Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever

Vanessa Raabe, Gerrit Kann, Bruce S. Ribner et al. · Clinical Infectious Diseases · 2017 · 133 citations · Full text

Epidemiologically Linked Cases, Virus Epidemiology, Viral Diagnostics +17